Get started Log in

COYA — Coya Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
$92.42m
Enterprise Value
$49.24m
Revenue
$7.95m

Brief: Coya Therapeutics To Expand Pipeline For COYA 302 Further, Adding Alzheimer's Disease To List Of Indications Expected To Be Validated In Clinic
21/02/2024 13:27
Brief: Coya Therapeutics Announces Pipeline Expansion Of Coya 302 To Include Frontotemporal Dementia To Parkinson’S And Amyotrophic Lateral Sclerosis
16/01/2024 13:17
Brief: Coya Therapeutics Announces Successful Pre-Ind And Type C Meetings With The FDA
05/01/2024 13:58
Brief: Coya Therapeutics Announces Closing Of $26.5 Million Private Placement
12/12/2023 13:29
India's Dr Reddy's gains on Coya deal for neurological disease treatment
07/12/2023 05:03
U.S. STOCKS ON THE MOVE-Coya, AeroVironment, Cleveland-Cliffs
06/12/2023 14:24
Coya up on deal with unit of India's Dr Reddy's for ALS therapy
06/12/2023 13:24
Brief: Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)
06/12/2023 12:09
Brief: Coya Therapeutics Announces $26.5 Million Private Placement
06/12/2023 12:08
Brief: Coya Announces Oral Presentation on Regulatory T Cell Expansion Strategy To Target Inflammation In Alzheimer’S Disease
27/10/2023 14:13
Brief: Coya Therapeutics Announces Completion Of Enrollment In Phase 2 Study Of Low Dose Interleukin-2 In Patients With Alzheimer’S Disease
09/10/2023 13:27
Brief: Coya Therapeutics Licenses Exclusive Worldwide Rights To Exosome Engineering Technology From Carnegie Mellon University
22/09/2023 15:16
Brief: Coya Therapeutics Announces Publication Of Potential Novel Blood Biomarker Data In Amyotrophic Lateral Sclerosis (Als) Patients
31/08/2023 13:38
Brief: Coya Therapeutics Increased Size Of Board To Six Directors From Five With Weinand's Appointment
21/08/2023 23:01
Brief: Former CEO And Chairman Of The Board Of Bayer Pharma AG, Dieter Weinand, Joins Coya’s Board Of Directors
21/08/2023 12:02
U.S. STOCKS ON THE MOVE-Argenx, ViewRay, Ford
17/07/2023 19:56
U.S. STOCKS ON THE MOVE-Activision Blizzard, Tesla, Paramount Global
17/07/2023 14:26
Coya Therapeutics rises on positive data for Alzheimer's disease therapy
17/07/2023 13:14
Brief: Coya Therapeutics Reports Additional Proof-Of-Concept Clinical Biomarker Data In Patients With Alzheimer’S Disease
17/07/2023 12:06
Factbox: Companies in Alzheimer's race after US nod for Eisai/Biogen drug
07/07/2023 19:20